Gene · 9775
Papers1,749
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,749
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stress decreases spermatozoa quality and induces molecular alterations in zebrafish progeny. | BMC Biol | 2023 | 37013516 | PubTator, text mining | PubMed |
| EIF4A3 Acts on the PI3K-AKT-ERK1/2-P70S6K Pathway through FLOT1 to Influence the Development of Lung Adenocarcinoma. | Mol Cancer Res | 2023 | 37011005 | PubTator, text mining | PubMed |
| Epitranscriptomics in the development, functions, and disorders of cancer stem cells. | Front Oncol | 2023 | 37007137 | PubTator, text mining | PubMed |
| Insights into circular RNAs: Biogenesis, function and their regulatory roles in cardiovascular disease. | J Cell Mol Med | 2023 | 37002786 | PubTator, text mining | PubMed |
| Co-phase separation of Y14 and RNA in vitro and its implication for DNA repair. | RNA | 2023 | 37001915 | PubTator, text mining | PubMed |
| Hsa_circ_0001162 Inhibition Alleviates High Glucose-Induced Human Podocytes Injury by the miR-149-5p/MMP9 Signaling Pathway. | Appl Biochem Biotechnol | 2023 | 36988849 | PubTator, text mining | PubMed |
| Nonsense-Mediated mRNA Decay Factor Functions in Human Health and Disease. | Biomedicines | 2023 | 36979701 | PubTator, text mining | PubMed |
| Recoding of Nonsense Mutation as a Pharmacological Strategy. | Biomedicines | 2023 | 36979640 | PubTator, text mining | PubMed |
| The function and mechanisms of action of circular RNAs in Urologic Cancer. | Mol Cancer | 2023 | 36966306 | PubTator, text mining | PubMed |
| Modeling structure-activity relationships with machine learning to identify GSK3-targeted small molecules as potential COVID-19 therapeutics. | Front Endocrinol (Lausanne) | 2023 | 36950681 | PubTator, text mining | PubMed |
| Biological functions, mechanisms, and clinical significance of circular RNA in colorectal cancer. | Front Oncol | 2023 | 36950552 | PubTator, text mining | PubMed |
| circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling. | J Exp Clin Cancer Res | 2023 | 36932454 | PubTator, text mining | PubMed |
| Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. | Mol Cancer | 2023 | 36932387 | PubTator, text mining | PubMed |
| PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer. | Mol Cell Proteomics | 2023 | 36931626 | PubTator, text mining | PubMed |
| Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets. | Front Genet | 2023 | 36926585 | PubTator, text mining | PubMed |
| Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36902316 | PubTator, text mining | PubMed |
| Transcriptomic Analyses of Brains of RBM8A Conditional Knockout Mice at Different Developmental Stages Reveal Conserved Signaling Pathways Contributing to Neurodevelopmental Diseases. | Int J Mol Sci | 2023 | 36902031 | PubTator, text mining | PubMed |
| Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. | Int J Mol Sci | 2023 | 36901717 | PubTator, text mining | PubMed |
| EIF4A3 induced circABCA5 promotes the gastric cancer progression by SPI1 mediated IL6/JAK2/STAT3 signaling. | Am J Cancer Res | 2023 | 36895988 | PubTator, text mining | PubMed |
| Circ-USP9X interacts with EIF4A3 to promote endothelial cell pyroptosis by regulating GSDMD stability in atherosclerosis. | Clin Exp Hypertens | 2023 | 36890708 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9775/papers?page=17